TNF and inflammatory bowel disease: Among the medications used to treat IBD, corticosteroids, immunomodulators and anti-TNF agents were prescribed in 57.4, 26.8 and 5.4% of the IBD cohort, respectively, and were used more frequently compared to non-IBD controls (Table 1).